

Hugh Risebrow
Managing Director
Latchmore Associates
Hugh is currently managing director of Latchmore Associates, a healthcare advisory boutique which supports both public and private sector healthcare organisations to develop and implement commercial strategy and to create commercial partnerships. Projects include:
- Working with six NHS STP regions, and an Irish hospital group on the integration of pathology services
- Advising eleven NHS trusts to develop private and overseas patient strategy
- Advising three Trusts on commercial revenue generation options
- Advising a European hospital group on their entry to the UK market, leading to the opening of a new private orthopaedic hospital
- Advising a European pathology group on UK market entry options, including initiating discussions with three acquisition targets
- Advising a digital pathology provider on private healthcare opportunities
- Advising an FDA approved histology AI provider
- Helping early stage healthcare technology companies to develop NHS partnerships
Previous positions include:
- UK CEO of synlab, Europe’s leading pathology group, where he created a JV with The Christie
- Commercial director at Guy’s & St Thomas
- CEO of Interhealth Canada in Europe
- Business development director of United Health Europe
- CEO BUPA Dental
- CEO Aid-Call
His early career was in strategic consultancy with Bain & Co. He is an engineering graduate from Cambridge University.
Hear me speak at HBI
The investment opportunity in fertility and women’s health
The fertility sector continues to steadily grow, but with a fragmented market, consolidation is not straightforward. And the revolution to address health inequalities for women presents a huge opportunity –...
Whittle - 3rd Floor












Seeking Efficiency: How tech is impacting operations
In a world of complexity, of rising costs, waiting lists and staff shortages, finding efficiency within your existing operations and resources is critical not only to staying afloat but to...
Fleming - 3rd Floor










Investing in Health Care Property
A conversation with some of the largest health care property investors discussing topics such as: How robust is health care real estate to rising inflation? What ESG frameworks are in...
St James - 4th Floor
















